Vaxcyte, Inc. (PCVX)
65.27
-2.28
(-3.38%)
USD |
NASDAQ |
Oct 15, 16:00
65.20
-0.07
(-0.11%)
After-Hours: 20:00
Vaxcyte Cash from Operations (TTM) : -881.23M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -881.23M |
| March 31, 2026 | -769.93M |
| December 31, 2025 | -655.58M |
| September 30, 2025 | -542.15M |
| June 30, 2025 | -459.55M |
| March 31, 2025 | -459.78M |
| December 31, 2024 | -452.63M |
| September 30, 2024 | -470.04M |
| June 30, 2024 | -466.88M |
| March 31, 2024 | -408.22M |
| December 31, 2023 | -296.79M |
| September 30, 2023 | -233.20M |
| June 30, 2023 | -214.20M |
| March 31, 2023 | -190.58M |
| Date | Value |
|---|---|
| December 31, 2022 | -170.60M |
| September 30, 2022 | -156.47M |
| June 30, 2022 | -146.34M |
| March 31, 2022 | -135.89M |
| December 31, 2021 | -121.39M |
| September 30, 2021 | -81.07M |
| June 30, 2021 | -65.71M |
| March 31, 2021 | -46.10M |
| December 31, 2020 | -46.63M |
| September 30, 2020 | -51.36M |
| June 30, 2020 | -47.77M |
| March 31, 2020 | -52.21M |
| December 31, 2019 | -48.24M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Vir Biotechnology, Inc. | -202.51M |
| Revolution Medicines, Inc. | -1.223B |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |